Volume 21 Number 12
31 December 2019

Home > Publications > Current Neuro-Oncology > Volume 21, Year 2019 > Number 12, 31 December

Baran O, Kemerdere R, Korkmaz TS, Kayhan A, Tanriverdi T.
Can preoperative neutrophil to lymphocyte, lymphocyte to monocyte, or platelet to lymphocyte ratios differentiate glioblastoma from brain metastasis?
Medicine (Baltimore).
2019 Dec;98(50):e18306. doi: 10.1097/MD.0000000000018306. PMID: 31852112. Observational study. ˍ

Hidalgo Santos AD, de Mingo Alemany MDC, Moreno Macián F, León Cariñena S, Collado Ballesteros E, Cañete Nieto A.
Endocrinological late effects of oncologic treatment on survivors of medulloblastoma.
Rev Chil Pediatr. 2019 Dec;90(6):598-605. doi: 10.32641/rchped.v90i6.994? PMID: 32186582. Observational study. ˍ

Muto J, Matsutani T, Matsuda R, Kinoshita M, Oikawa M, Pallud J, Sasaki H.
Temozolomide radiochemotherapy for high-grade glioma patients with hemodialysis: a case series of 7 patients.
Neurooncol Pract. 2019 Dec 3. 2020;7(1):111-117. doi: 10.1093/nop/npz034. PMID: 32025326. Observational study. ˍ

Wang Y, Meng X, Zhou S, Zhu Y, Xu J, Tao R.
Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study.
Onco Targets Ther. 2019 Dec 3, 2019;12:10579–10585. doi:10.2147/OTT.S226804. PMID: 31819537. Interventional study. ˍ

Vankipuram S, Sahoo S, Bhalla S, Srivastava C.
Do Glioblastomas with Syndromic Association Have Better Prognosis? A Case of Supratentorial Glioblastoma with Embryonal Tumor Differentiation in a Child with Multiple Enchondromatosis.
J Pediatr Neurosci. 2019 Dec 5, 2019;14(4):228-231. doi: 10.4103/jpn.JPN_82_19. PMID: 31908666. Case report. ˍ

Hargrave DR, Bouffet E, Tabori U, et al.
Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study.
Clin Cancer Res. 2019 Dec 6, 2019;25(24):7303–7311. doi:10.1158/1078-0432.CCR-19-2177. PMID: 31811016.Interventional study. ˍ

Jung J, Tailor J, Dalton E, Glancz LJ, Roach J, Zakaria R, Lammy S, Chari A, Budohoski KP, Livermore LJ, Yu K, Jenkinson MD, Brennan PM, Brazil L, Bunce C, Bourmpaki E, Ashkan K, Vergani F.
Management evaluation of metastasis in the brain (MEMBRAIN)-a United Kingdom and Ireland prospective, multicenter observational study.
Neurooncol Pract. 2019 Dec 6, 2020;7(3):344-355. doi: 10.1093/nop/npz063. PMID: 32537183. Observational study. ˍ

Cloughesy TF, Brenner A, de Groot JF, Butowski NA, Zach L, Campian JL, Ellingson BM, Freedman LS, Cohen YC, Lowenton-Spier N, Rachmilewitz Minei T, Shmueli SF; GLOBE Study Investigators, Wen PY.
A randomized controlled phase III study of VB-111 combined with bevacizumab vs. bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).
Neuro Oncol. 2019 Dec 7, 2020;22(5):705-717. doi: 10.1093/neuonc/noz232. PMID: 31844890. Interventional study. ˍ

Henderson F Jr, Brem S, O'Rourke DM, Nasrallah M, Buch VP, Young AJ, Doot RK, Pantel A, Desai A, Bagley SJ, Nabavizadeh SA.
18F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling.
Neurooncol Pract. 2019 Dec 8, 2020;7(2):152-157. doi: 10.1093/nop/npz068. PMID: 32206320. Case report. ˍ

Drewes AM, Møller M, Hertzum-Larsen R, Engholm G, Storm H.
Risk of primary brain tumour after breast cancer.
Endocr Connect. 2019 Dec 9, 2020;9(1):28-33. doi: 10.1530/EC-19-0498. PMID: 31821158. Observational study. ˍ

Ashwath KG, Aggarwal A, Praneeth K, Singla N, Gupta K.
Neutrophil-to-Lymphocyte Ratio: Can It Be Used as an Adjunct Tool to Predict Histopathological Grade of Brain Tumor?
J Neurosci Rural Pract. 2019 Dec 11, 2019;10(4):648-652. doi: 10.1055/s-0039-3399489. PMID: 31831985. Interventional study. ˍ

Lazaridis L, Schäfer N, Teuber-Hanselmann S, Blau T, Schmidt T, Oster C, Weller J, Tzaridis T, Pierscianek D, Keyvani K, Kleinschnitz C, Stuschke M, Scheffler B, Deuschl C, Sure U, Herrlinger U, Kebir S, Glas M.
Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma.
J Cancer Res Clin Oncol. 2019 Dec 11, 2020;146(3):787-792. doi: 10.1007/s00432-019-03106-8. PMID: 31828428. Observational study. ˍ

Corti C, Urgesi C, Massimino M, Gandola L, Bardoni A, Poggi G.
Effects of supratentorial and infratentorial tumor location on cognitive functioning of children with brain tumor.
Childs Nerv Syst. 2019 Dec 12, 2020;36(3):513-524. doi: 10.1007/s00381-019-04434-3. PMID: 31832765. Observational study. ˍ

Huang Q, Li F, Chen Y, Hong F, Wang H, Chen J.
Prognostic factors and clinical outcomes in adult primary gliosarcoma patients: a Surveillance, Epidemiology, and End Results (SEER) analysis from 2004 to 2015.
Br J Neurosurg. 2019 Dec 12, 2020;34(2):161-167. doi: 10.1080/02688697.2019.1699903. PMID: 31829033. Observational study. ˍ

Ahn S, Park JS, Jang J, Ahn KJ, Hong YK, Yang SH, Jeun SS.
The association between total lymphocyte count after concomitant chemoradiation and overall survival in patients with newly diagnosed glioblastoma.
J Clin Neurosci. 2019 Dec 13, 2020;71:21-25. doi: 10.1016/j.jocn.2019.11.017. PMID: 31843432. Observational study. ˍ

Morais BA, Solla DJF, Matushita H, Teixeira MJ, Monaco BA.
Pediatric intrinsic brainstem lesions: clinical, imaging, histological characterization, and predictors of survival.
Childs Nerv Syst. 2019 Dec 13, 2020;36(5):933-939. doi: 10.1007/s00381-019-04453-0. PMID: 31836906. Observational study. ˍ

Nie Q, Hsiao MC, Chandok H, Rowe S, Prego M, Meyers B, Omerza G, Hesse A, Uvalic J, Soucy M, Bergeron D, Peracchio M, Burns S, Kelly K, Rueter J, Reddi HV.
Molecular profiling of CNS tumors for the treatment and management of disease.
J Clin Neurosci.
2019 Dec 16, 2020;71:311-315. doi: 10.1016/j.jocn.2019.11.035. PMID: 31859178. Laboratory investigation. ˍ

Schatlo B, Stockhammer F, Barrantes-Freer A, Bleckmann A, Siam L, Pukrop T, Rohde V.
5-Aminolevulinic Acid Fluorescence Indicates Perilesional Brain Infiltration in Brain Metastases.
World Neurosurg X. 2019 Dec 16, 2020 Jan;5:100069. doi: 10.1016/j.wnsx.2019.100069. PMID: 32095783. Interventional study. ˍ

Aiello G, Ballabio C, Ruggeri R, Fagnocchi L, Anderle M, Morassut I, Caron D, Garilli F, Gianno F, Giangaspero F, Piazza S, Romanel A, Zippo A, Tiberi L.
Truncated BRPF1 Cooperates with Smoothened to Promote Adult Shh Medulloblastoma.
Cell Rep.
2019 Dec 17, 2019;29(12):4036-4052.e10. doi: 10.1016/j.celrep.2019.11.046. PMID: 31851932. Laboratory investigation. ˍ

Brenner AJ, Peters KB, Vredenburgh J, Bokstein F, Blumenthal DT, Yust-Katz S, Peretz I, Oberman B, Freedman LS, Ellingson BM, Cloughesy TF, Sher N, Cohen YC, Lowenton-Spier N, Rachmilewitz Minei T, Yakov N, Mendel I, Breitbart E, Wen PY.
Safety and efficacy of VB-111, an anti-cancer gene-therapy, in patients with recurrent glioblastoma: results of a phase I/II study.
Neuro Oncol. 2019 Dec 17, 2020;22(5):694-704. doi: 10.1093/neuonc/noz231. PMID: 31844886. Interventional study. ˍ

Frandsen S, Broholm H, Larsen VA, Grunnet K, Møller S, Poulsen HS, Michaelsen SR.
Clinical Characteristics of Gliosarcoma and Outcomes From Standardized Treatment Relative to Conventional Glioblastoma.
Front Oncol. 2019 Dec 17;9:1425. doi: 10.3389/fonc.2019.01425. PMID: 31921679. Observational study. ˍ

Giagnacovo M, Antonelli M, Biassoni V, Schiavello E, Warmuth-Metz M, Buttarelli FR, Modena P, Massimino M.
Retrospective analysis on the consistency of MRI features with histological and molecular markers in diffuse intrinsic pontine glioma (DIPG).
Childs Nerv Syst. 2019 Dec 17, 2020;36(4):697-704. doi: 10.1007/s00381-019-04463-y. PMID: 31848724. Observational study. ˍ

Bernstock JD, Alva E, Cohen JL, Lobbous M, Chagoya G, Elsayed GA, Orr BA, Rozzelle C, Rocque B, Blount J, Johnston JM, Li R, Fiveash JB, Dhall G, Reddy AT, Friedman GK.
Treatment of pediatric high-grade central nervous system tumors with high-dose methotrexate in combination with multiagent chemotherapy: A single-institution experience.
Pediatr Blood Cancer. 2019 Dec 18, 2020;67(3):e28119. doi: 10.1002/pbc.28119. PMID: 31850678. Observational study. ˍ

Li G, Zhai Y, Wang Z, Wang Z, Huang R, Jiang H, Li R, Feng Y, Chang Y, Jiang T, Zhang W.
Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages.
Cancer Med.
2019 Dec 18, 2020;9(6):1955-1965. doi: 10.1002/cam4.2754. PMID: 31851783. Observational study. ˍ

Vaitkiene P, Urbanaviciute R, Grigas P, Steponaitis G, Tamasauskas A, Skiriutė D.
Identification of Astrocytoma Blood Serum Protein Profile.
2019 Dec 19, 2019;9(1):16. doi: 10.3390/cells9010016. PMID: 31861636. Laboratory investigation. ˍ

Huang RY, Guenette JP.
Non-invasive Diagnosis of H3 K27M Mutant Midline Glioma.
Neuro Oncol.
2019 Dec 20, 2020;22(3):309-310. doi: 10.1093/neuonc/noz240. PMID: 31858137. Comment. ˍ
Refers to: Su X, et al., Automated Machine Learning Based on Radiomics Features Predicts H3 K27M Mutation in Midline Gliomas of the Brain.
Neuro Oncol. 2019 Sep 29, 2020;22(3):393-401
. doi: 10.1093/neuonc/noz184. PMID: 31563963. Observational study. ˍ

Jiang N, Larrazabal R, Alsunbul W, Lu JQ.
Angiosarcomatous component in gliosarcoma: case report and consideration of diagnostic challenge and hemorrhagic propensity.
J Biomed Res. 2019 Dec 20. 2020;34(2):143–148. doi: 10.7555/JBR.33.20190080. PMID: 32305969. Case report. ˍ

Shen E, Johnson MO, Lee JW, Lipp ES, Randazzo DM, Desjardins A, McLendon RE, Friedman HS, Ashley DM, Kirkpatrick JP, Peters KB, Walsh KM.
Performance of a nomogram for IDH-wild-type glioblastoma patient survival in an elderly cohort.
Neurooncol Adv. 2019 Dec 20, 2019;1(1):vdz036. doi: 10.1093/noajnl/vdz036. PMID: 32642665. Letter to the editor. ˍ
Refers to: Gittleman H, et al., An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival.
Neurooncol Adv. 2019 May 30, 2019;1(1):vdz007
. doi: 10.1093/noajnl/vdz007. PMID: 31608326. Observational study. ˍ

Zhou N, Wei ZX, Qi ZX.
Inhibition of autophagy triggers melatonin-induced apoptosis in glioblastoma cells.
BMC Neurosci. 2019 Dec 23, 2019;20(1):63. doi: 10.1186/s12868-019-0545-1. PMID: 31870319. Laboratory investigation. ˍ

Kerezoudis P, Goyal A, Lu VM, Alvi MA, Bydon M, Kizilbash SH, Burns TC.
The role of radiation and chemotherapy in adult patients with high-grade brainstem gliomas: results from the National Cancer Database.
J Neurooncol.
2019 Dec 24, 2020;146(2):303-310. doi: 10.1007/s11060-019-03374-x. PMID: 31873874. Observational study. ˍ

Pilati E, Nicolotti DG, Ceci F, Finessi M, Cerio I, Dionisi B, Zotta M, Bellò M, Deandreis D.
68Ga-Prostate-Specific Membrane Antigen 11 PET/CT Detects Residual Glioblastoma After Radical Surgery in a Patient With Synchronous Recurrent Prostate Cancer: A Case Report.
Clin Nucl Med.
2019 Dec 24, 2020;45(3):e151-e153. doi: 10.1097/RLU.0000000000002884. PMID: 31876821. Case report. ˍ

Tiwari S, Yadav T, Pamnani J, Mathew JM, Elhence P, Praneeth K, Vedant D, Khera PS, Garg P, Vyas V.
Diffuse Leptomeningeal Glioneuronal Tumor: A Unique Leptomeningeal Tumor Entity.
World Neurosurg. 2019 Dec 30, 2020;135:297-300 ˍ. doi: 10.1016/j.wneu.2019.12.119. PMID: 31899391. Case report. ˍ

Richards A, Ved R, Murphy C, Hennigan D, Kilday JP, Kamaly-Asl I, Mallucci C, Bhatti I, Patel C, Leach P.
Outcomes with respect to extent of surgical resection for pediatric atypical teratoid rhabdoid tumors.
Childs Nerv Syst. 2019 Dec 31, 2020;36(4):713-719. doi: 10.1007/s00381-019-04478-5. PMID: 31889208. Observational study. ˍ

Sallabanda K, Yañez L, Sallabanda M, Santos M, Calvo FA, Marsiglia H.
Stereotactic Radiosurgery for the Treatment of Recurrent High-grade Gliomas: Long-term Follow-up.
Cureus. 2019 Dec 31, 2019;11(12):e6527. doi: 10.7759/cureus.6527. PMID: 31911881. Observational study. ˍ

Shamov TP, Tivcheva I, Eftimov T.
Postoperative Cerebellar Mutism Syndrome in an Adult Patient.
Folia Med (Plovdiv). 2019 Dec 31, 2019;61(4):630‐633. doi: 10.3897/folmed.61.e47829. PMID: 32337887. Case report. ˍ